Financials
- Market Capitalization 20.32 M
- Employee 8
- Founded 1996
- CEO N/A
- Website www.neuphoriatx.com
- Headquarter Australia
- FIGI BBG01RFZ8658
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-0.42
Relación precio/flujo de caja
207.27
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 4537 | LGVN Longeveron Inc. - Class A Common stock | 6.90 USD | +2.68% | +845.21% | +871.83% | +1107.77% | 22.00 M USD | ||
| 4562 | DYAI Dyadic International, Inc. - Common Stock | 0.56 USD | -8.20% | -20.00% | -46.15% | -38.46% | 20.41 M USD | ||
| 4565 | AKTX Akari Therapeutics Plc - American Depositary Shares | 10.43 USD | -2.52% | +30.87% | +38.88% | +1254.55% | 20.31 M USD | ||
| 4566 | ENLV Enlivex Ltd. - Ordinary Shares | 1.28 USD | -5.19% | -14.09% | -40.19% | +23.08% | 20.26 M USD |